These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9378048)

  • 41. [Medical prophylaxis and treatment of steroid induced osteoporosis].
    Rødevand E; Mikkelsen K; Nordvåg BY; Haga HJ; Førre Ø; Johnsen V; Kvien TK
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1643-5. PubMed ID: 15976829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of osteoporosis with fluoride.
    Riggs BL; Jowsey J
    Semin Drug Treat; 1972; 2(1):27-33. PubMed ID: 5048562
    [No Abstract]   [Full Text] [Related]  

  • 43. Supplementation of vitamin D plus calcium is effective in corticosteroid-induced osteoporosis management.
    Bijlsma JW
    Clin Exp Rheumatol; 2000; 18(1):3-4. PubMed ID: 10777337
    [No Abstract]   [Full Text] [Related]  

  • 44. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Osteoporosis in men--diagnosis and treatment].
    Abrahamsen B; Hyldstrup L; Brixen KT
    Ugeskr Laeger; 2005 Feb; 167(8):901-5. PubMed ID: 15789845
    [No Abstract]   [Full Text] [Related]  

  • 46. [Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].
    Benucci M; Dolenti S; Saviola G; Manfredi M
    Recenti Prog Med; 2006 Jan; 97(1):24-7. PubMed ID: 16535926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corticosteroid-induced osteoporosis.
    Adachi JD
    Am J Med Sci; 1997 Jan; 313(1):41-9. PubMed ID: 9001165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of osteoporosis].
    Yamazaki K; Inoue T
    Nihon Rinsho; 1990 Dec; 48(12):2916-21. PubMed ID: 2086855
    [No Abstract]   [Full Text] [Related]  

  • 49. Zoledronic acid--once-yearly. Corticosteroid-induced osteoporosis: no benefit.
    Prescrire Int; 2010 Apr; 19(106):63. PubMed ID: 20568485
    [No Abstract]   [Full Text] [Related]  

  • 50. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup.
    Sato S; Ohosone Y; Suwa A; Yasuoka H; Nojima T; Fujii T; Kuwana M; Nakamura K; Mimori T; Hirakata M
    J Rheumatol; 2003 Dec; 30(12):2673-9. PubMed ID: 14719212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Osteoporosis prophylaxis prescribing patterns in ophthalmology patients treated with long-term corticosteroids.
    Walker RA; Hall RB; Pekush RD; Taylor-Gjevre RM
    Can J Ophthalmol; 2010 Feb; 45(1):81-2. PubMed ID: 20130720
    [No Abstract]   [Full Text] [Related]  

  • 53. [Concurrent treatment of osteoporosis with bisphosphonate and vitamin K2].
    Shiraki M
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():466-9. PubMed ID: 15035172
    [No Abstract]   [Full Text] [Related]  

  • 54. [Calcium and vitamin D preparations in steroid osteoporosis in patients with rheumatoid arthritis].
    Bazhenov AN; Plesovskaia IV; Iliushina LV
    Ter Arkh; 2007; 79(5):89-92. PubMed ID: 17672084
    [No Abstract]   [Full Text] [Related]  

  • 55. [Utilization of calcium, vitamin D and diphosphonates used in the treatment of osteoporosis in Denmark 1994-1996. An epidemiological analysis of nationwide prescription data].
    Juul KV
    Ugeskr Laeger; 1998 May; 160(22):3207-11. PubMed ID: 9621798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
    Papapoulos SE
    Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
    [No Abstract]   [Full Text] [Related]  

  • 57. Management of corticosteroid-induced osteoporosis.
    Stevenson JC
    Lancet; 1998 Oct; 352(9137):1327-8. PubMed ID: 9802265
    [No Abstract]   [Full Text] [Related]  

  • 58. Vitamin D toxicity complicating the treatment of senile, postmenopausal, and glucocorticoid-induced osteoporosis. Four case reports and a critical commentary on the use of vitamin D in these disorders.
    Schwartzman MS; Franck WA
    Am J Med; 1987 Feb; 82(2):224-30. PubMed ID: 3812514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Action of calcitonin in peri- and post-menopausal osteoporosis and in osteoporosis induced by long-term treatment with cortisone].
    Notario A; Bravi M; Torriani A; Broglia M; Giuffrè G; Gianoglio G
    Clin Ter; 1987 Oct; 123(2):95-103. PubMed ID: 2972477
    [No Abstract]   [Full Text] [Related]  

  • 60. [Letter query to Zeitschrift für Rheumatologie by Dr. med. Ilka Schwarze FA of Internal Medicine and Rheumatology Center of Internal Medicine--Leipzig University Clinic].
    Scharla S
    Z Rheumatol; 2005 Mar; 64(2):138-9. PubMed ID: 15793680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.